113 related articles for article (PubMed ID: 7125868)
21. [Rectal absorption of phenobarbital in children as affected by different vehicles].
Heimann G; Neuwald F; Gladtke E
Arzneimittelforschung; 1978; 28(6):1023-6. PubMed ID: 581999
[TBL] [Abstract][Full Text] [Related]
22. [A study of pyramidone suppositories].
Mihalache M; Perţea M; Verbuţă A
Rev Med Chir Soc Med Nat Iasi; 1990; 94(2):389-92. PubMed ID: 2100858
[TBL] [Abstract][Full Text] [Related]
23. [Effect of temperature on drug release and drug absorption in mixed type diclofenac sodium suppositories].
Iwata M; Takayama K; Takahashi Y; Obata Y; Machida Y; Nagai T; Shirotake S
Yakugaku Zasshi; 1999 Feb; 119(2):170-7. PubMed ID: 10067431
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the discolouration developed in aged chloramphenicol suppositories.
Fadel H; Abd-Elbary A; Noureldin E; Kassem AA
Pharmazie; 1981 May; 36(5):362-5. PubMed ID: 7267686
[TBL] [Abstract][Full Text] [Related]
25. [A new vehicle for suppositories].
WIENHUSEN R
Pharmazie; 1952 Mar; 7(3):149-50. PubMed ID: 14948487
[No Abstract] [Full Text] [Related]
26. Softening and liquefaction temperature of suppositories.
SETNIKAR I; FANTELLI S
J Pharm Sci; 1963 Jan; 52():38-43. PubMed ID: 13988205
[No Abstract] [Full Text] [Related]
27. Polymorphic transition rate of semisynthetic fatty suppository bases.
Yoshino H; Kobayashi M; Samejima M
Chem Pharm Bull (Tokyo); 1981 Sep; 29(9):2661-9. PubMed ID: 7349284
[No Abstract] [Full Text] [Related]
28. [Research on rectal/resorption of I 131-labeled sodium from suppositories prepared with indigenous hydrogenated fats].
Verbuţă A; Baran T; Vasiliu I
Rev Med Chir Soc Med Nat Iasi; 1980; 84(2):299-303. PubMed ID: 7221288
[No Abstract] [Full Text] [Related]
29. Liquefaction times of fatty-type suppositories with and without progesterone.
Fulper LD; Cleary RW; Harland EC; Hikal AH; Jones AB
Am J Hosp Pharm; 1990 Mar; 47(3):602-3. PubMed ID: 2316546
[No Abstract] [Full Text] [Related]
30. Effect of drug solubility on the in vitro availability rate from suppositories with lipophilic excipients.
Realdon N; Ragazzi E; Ragazzi E
Pharmazie; 2000 May; 55(5):372-7. PubMed ID: 11828619
[TBL] [Abstract][Full Text] [Related]
31. Influence of the liquid phase coexisting in fatty suppository bases on the polymorphic transition rate.
Yoshino H; Kobayashi M; Samejima M
Chem Pharm Bull (Tokyo); 1982 Aug; 30(8):2941-50. PubMed ID: 7139836
[No Abstract] [Full Text] [Related]
32. [Advances in the field of excipients for suppositories].
NEUWALD F
J Pharm Belg; 1959; 14():392-400. PubMed ID: 14426734
[No Abstract] [Full Text] [Related]
33. In vitro methods for the evaluation of drug availability from suppositories: comparison between biological and artificial membranes.
Realdon N; Ragazzi E; Morpurgo M; Ragazzi E
Pharmazie; 2005 Oct; 60(10):756-60. PubMed ID: 16259123
[TBL] [Abstract][Full Text] [Related]
34. Impurities in drugs IV: Indomethacin.
Curran NM; Lovering EG; McErlane KM; Watson JR
J Pharm Sci; 1980 Feb; 69(2):187-9. PubMed ID: 7359321
[TBL] [Abstract][Full Text] [Related]
35. Effects of two different kinds of silicium dioxide on release of drugs from suppositories: benzydamine hydrochloride.
Dal Zotto M; Realdon N; Ragazzi E; Dalla Fini G
Farmaco; 1991 May; 46(5):699-711. PubMed ID: 1659426
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
[TBL] [Abstract][Full Text] [Related]
37. [Assay of a method for analysis of complex excipients for ointments and suppositories. II. Analysis of a complex mixture with a triglyceride base].
Aiache JM; Aiache S; Febvre P
Ann Pharm Fr; 1969 May; 27(5):343-52. PubMed ID: 5400821
[No Abstract] [Full Text] [Related]
38. Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositories.
Itoh S; Teraoka N; Matsuda T; Okamoto K; Takagi T; Oo C; Danny Kao H
Eur J Pharm Biopharm; 2006 Nov; 64(3):393-8. PubMed ID: 16890412
[TBL] [Abstract][Full Text] [Related]
39. [Experimental studies of synthetic vehicles for salves and suppositories].
HOFMANN H; HORNBOGEN U
Dtsch Gesundheitsw; 1950 Jul; 5(27):843-7. PubMed ID: 15435134
[No Abstract] [Full Text] [Related]
40. [Physicopharmaceutical characteristics of ulinastatin vaginal suppositories prepared in a hospital].
Satake K; Nakajima T; Iwata M; Fujikake Y; Kimura M
Yakugaku Zasshi; 2011; 131(11):1639-44. PubMed ID: 22041703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
